Eribulin Mesylate 10019-0080-01

Package NDC

10019-0080-01

Manufacturer: Baxter Healthcare Company
Dosage Form: Injection
Route: Intravenous
Product Type: Human Prescription Drug
Marketing Start: October 1, 2024
Listing Expires: December 31, 2027
Application: ANDA217250

Need to source Eribulin Mesylate? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.

Find Supply →Sponsored

Active Ingredients

Ingredient	Strength
Eribulin Mesylate	.5 mg/mL

Drug Class

Microtubule Inhibition [PE]Microtubule Inhibitor [EPC]

Selected Package

10019-0080-01Selected

1 VIAL, SINGLE-DOSE in 1 CARTON (10019-080-01) / 2 mL in 1 VIAL, SINGLE-DOSE